Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
11.12.25
/
50%
€7.16
Target price
11.12.26
-
Performance (%)
98.60%
Price
17.04.26
€12.40
Summary
This prediction is currently active. With a performance of 98.60% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 11.12.26. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Corvus Pharmaceuticals Inc | -4.580% | -4.580% |
| iShares Core DAX® | 3,59 % | 6,43 % |
| iShares Nasdaq 100 | 5,81 % | 6,38 % |
| iShares Nikkei 225® | 4,08 % | 9,31 % |
| iShares S&P 500 | 4,14 % | 4,94 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals (NASDAQ:CRVS) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.67
01.04.24
01.04.24
-
01.04.25
01.04.25
71.74%
02.04.25
02.04.25
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
146.36%
08.09.24
08.09.24